Posted inBiotechnology
Ceperognastat Shows Promise in Early Symptomatic Alzheimer’s Disease Treatment
A recent study published in JAMA has tested the efficacy of Ceperognastat, an innovative oral small-molecule inhibitor targeting O-linked N-acetylglucosaminidase…







